Author

Ayse Dudu Altintas Dogan

Observed name: Altintas Dogan, Ayse Dudu

Institution: Regional Hospital Horsens

Observed institutions: University of Southern Denmark, Odense University Hospital, Vejle Sygehus, Regional Hospital Horsens, Hospital South West Jutland, Lillebaelt Hospital, Sygehus Sønderjylland

ORCID: 0000-0001-6953-9969

Observed ORCID: 0000-0001-6953-9969

OpenAlex ID: A5065497791

Respiratory Effects of Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in Patients Suffering from Obesity and Chronic Obstructive Pulmonary Disease

2022 · Ayse Dudu Altintas Dogan, Ole Hilberg, et al. · International Journal of COPD · 66

Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion

2016 · Ayse Dudu Altintas Dogan, Ulla Linding Jørgensen, et al. · Journal of Diabetes Science and Technology · 16

FDG-PET/CT-based respiration-gated lung segmentation and quantification of lung inflammation in COPD patients

2024 · Ayse Dudu Altintas Dogan, Thomas Quist Christensen, et al. · BMC Research Notes · 3

[The tropical disease Chikungunya fever has come to Europe].

2013 · Ayse Dudu Altintas Dogan, Kristin Bunes, et al. · PubMed · 3

Effects of Treatment with Liraglutide on Health-Related Quality of Life and Obstructive Sleep Apnea in People with Obesity and Chronic Obstructive Pulmonary Disease

2022 · Ayse Dudu Altintas Dogan, Søren Hess, et al. · Research Square · 2

Exploratory Analysis of Liraglutide Effects on Obstructive Sleep Apnea and Health‐Related Quality of Life in Individuals With Obesity and COPD : A Secondary Analysis of a Randomised Controlled Trial

2026 · Sofie Krogh Wolsing, Ayse Dudu Altintas Dogan, et al. · Clinical Obesity

Works count: 7

Citation count: 90

H-index: 3

I10-index: 2